Operating Cash Flow
Eli Lilly Operating Cash Flow increased by 65.4% to $5.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 220.1%, from $1.67B to $5.33B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 22.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.78B | $1.63B | $2.26B | $2.52B | $1.18B | $2.22B | $1.66B | $1.73B | $631.90M | $2.19B | $0.00 | $1.17B | $1.47B | $3.71B | $2.47B | $1.67B | $3.09B | $8.84B | $3.22B | $5.33B |
| QoQ Change | — | -8.1% | +38.6% | +11.6% | -53.1% | +87.3% | -25.0% | +4.1% | -63.5% | +246.5% | -100.0% | — | +25.7% | +153.2% | -33.4% | -32.7% | +85.3% | +186.3% | -63.5% | +65.4% |
| YoY Change | — | — | — | — | -33.4% | +35.9% | -26.5% | -31.4% | -46.6% | -1.2% | -100.0% | -32.6% | +132.0% | +69.5% | — | +42.9% | +110.5% | +138.0% | +30.3% | +220.1% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Eli Lilly's operating cash flow?
- Eli Lilly (LLY) reported operating cash flow of $5.33B in Q1 2026.
- How has Eli Lilly's operating cash flow changed year-over-year?
- Eli Lilly's operating cash flow increased by 220.1% year-over-year, from $1.67B to $5.33B.
- What is the long-term trend for Eli Lilly's operating cash flow?
- Over 4 years (2021 to 2025), Eli Lilly's operating cash flow has grown at a 22.9% compound annual growth rate (CAGR), from $7.37B to $16.81B.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.